We have recently demonstrated that activation of these pathways can be triggered by the estrogen receptor alpha (ESR1) [7], a gene overexpressed in ACC that mediates estrogen-dependent proliferative effects [7, 8]. This evidence concerns the gene ESR1 and adrenal cortex carcinoma.